199 tracked 13F filers disclose a position in NKTR as of the latest SEC 13F filings, a combined $2.0B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | $309.6M | 4.3M | ▲43× Added · +4.2M sh | Q1 2026 | |
| 2 | BVF INC/IL | $184.2M | 2.6M | ▲+64% Added · +1.0M sh | Q1 2026 | |
| 3 | Two Seas Capital LP | $141.0M | 2.0M | ▲+163% Added · +1.2M sh | Q1 2026 | |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $86.1M | 1.2M | →First observed position No prior filed position | Q1 2026 | |
| 5 | TWO SIGMA INVESTMENTS, LP | $67.0M | 931K | ▲+97% Added · +458K sh | Q1 2026 | |
| 6 | STATE STREET CORP | $63.5M | 910K | ▲+272% Added · +665K sh | Q2 2026 | |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $61.5M | 881K | ▲+154% Added · +535K sh | Q2 2026 | |
| 8 | Prosight Management, LP | $52.9M | 735K | ▲+33% Added · +180K sh | Q1 2026 | |
| 9 | BlackRock, Inc. | $49.8M | 693K | ▲+7.3% Added · +47K sh | Q1 2026 | |
| 10 | MORGAN STANLEY | $47.4M | 659K | ▲+16% Added · +93K sh | Q1 2026 | |
| 11 | GILDER GAGNON HOWE & CO LLC | $41.9M | 601K | ▲+121% Added · +329K sh | Q2 2026 | |
| 12 | ARMISTICE CAPITAL, LLC | $41.6M | 578K | ▼−3.0% Reduced · −18K sh | Q1 2026 | |
| 13 | CITADEL ADVISORS LLC | $36.9M | 514K | ▲+66% Added · +204K sh | Q1 2026 | |
| 14 | BRAIDWELL LP | $33.1M | 474K | ▲+113% Added · +251K sh | Q2 2026 | |
| 15 | Sofinnova Investments, Inc. | $32.9M | 472K | ▼−7.4% Reduced · −38K sh | Q2 2026 | |
| 16 | Woodline Partners LP | $29.9M | 415K | ▲+299% Added · +311K sh | Q1 2026 | |
| 17 | MILLENNIUM MANAGEMENT LLC | $29.1M | 404K | ▼−11% Reduced · −50K sh | Q1 2026 | |
| 18 | Qube Research & Technologies Ltd | $28.1M | 391K | ▲+21% Added · +67K sh | Q1 2026 | |
| 19 | EMERALD ADVISERS, LLC | $27.2M | 390K | ▼−1.1% Reduced · −4K sh | Q2 2026 | |
| 20 | UBS Group AG | $23.0M | 320K | ▲+11% Added · +33K sh | Q1 2026 | |
| 21 | GREAT POINT PARTNERS LLC | $22.8M | 316K | ▲+50% Added · +106K sh | Q1 2026 | |
| 22 | Vestal Point Capital, LP | $20.5M | 285K | ▲New +285K sh | Q1 2026 | |
| 23 | 22NW, LP | $19.6M | 281K | —Held | Q2 2026 | |
| 24 | PRIMECAP MANAGEMENT CO/CA/ | $20.1M | 279K | ▼−0.3% Reduced · −1K sh | Q1 2026 | |
| 25 | ORBIMED ADVISORS LLC | $19.8M | 275K | ▲New +275K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 13 funds opened a new position in NKTR and 36 added to an existing one, while 13 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 99 funds | $85.6B |
| MICROSOFT CORPMSFT | 97 funds | $115.9B |
| NVIDIA CORPNVDA | 94 funds | $179.2B |
| META PLATFORMS INC-CLASS AMETA | 94 funds | $48.8B |
| BROADCOM INCAVGO | 91 funds | $67.5B |
| MICRON TECHNOLOGY INCMU | 91 funds | $27.4B |
| ALPHABET INC-CL AGOOGL | 90 funds | $66.6B |
| INTUITIVE SURGICAL INCISRG | 90 funds | $14.3B |
| ELI LILLY & COLLY | 88 funds | $42.9B |
| ADVANCED MICRO DEVICESAMD | 85 funds | $19.4B |
| UNITEDHEALTH GROUP INCUNH | 85 funds | $14.2B |
| LAM RESEARCH CORPLRCX | 85 funds | $13.9B |
Ranked by how many of NKTR's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 418 | $30K |
| Aug 18, 2026 | Zalevsky Jonathan | Chief R&D Officer | Sell (S) | 186 | $13K |
| Jun 30, 2026 | Zalevsky Jonathan | Chief R&D Officer | Sell (S) | 6K | $398K |
| Jun 17, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 6K | $334K |
| Jun 17, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 5K | $277K |
| Jun 16, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 5K | $318K |
| Jun 16, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 5K | $285K |
| Jun 15, 2026 | Zalevsky Jonathan | Chief R&D Officer | Sell (S) | 6K | $336K |
| May 19, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 444 | $29K |
| May 19, 2026 | Zalevsky Jonathan | Chief R&D Officer | Sell (S) | 199 | $13K |
| Feb 18, 2026 | ROBIN HOWARD W | President & CEO, Director | Sell (S) | 423 | $31K |
| Feb 18, 2026 | Zalevsky Jonathan | Chief R&D Officer | Sell (S) | 180 | $13K |
| Class | 13F holders | Value held |
|---|---|---|
| NKTRthis pageStock | 199 funds | $2.0B |
| NKTREURStock | 6 funds | $90K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for NKTR
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/NKTR/capital-change-brief"
Use Arkolith's capital_change_brief for NKTR. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NKTR. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.